These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10635615)

  • 21. The genetics of generalized vitiligo.
    Spritz RA
    Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanocytes derived from patients with Hermansky-Pudlak Syndrome types 1, 2, and 3 have distinct defects in cargo trafficking.
    Richmond B; Huizing M; Knapp J; Koshoffer A; Zhao Y; Gahl WA; Boissy RE
    J Invest Dermatol; 2005 Feb; 124(2):420-7. PubMed ID: 15675963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcellular distribution of tyrosinase and tyrosinase-related protein-1: implications for melanosomal biogenesis.
    Orlow SJ; Boissy RE; Moran DJ; Pifko-Hirst S
    J Invest Dermatol; 1993 Jan; 100(1):55-64. PubMed ID: 8423398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The molecular mechanism for lysosome biogenesis].
    Fujita H; Tanaka Y; Himeno M
    Fukuoka Igaku Zasshi; 2003 Sep; 94(9):259-66. PubMed ID: 14639964
    [No Abstract]   [Full Text] [Related]  

  • 25. Human pigmentation genetics: the difference is only skin deep.
    Sturm RA; Box NF; Ramsay M
    Bioessays; 1998 Sep; 20(9):712-21. PubMed ID: 9819560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of serum anti-melanocyte antibodies and identification of related antigens in patients with vitiligo.
    Zhu MC; Liu CG; Wang DX; Zhan Z
    Genet Mol Res; 2015 Dec; 14(4):16060-73. PubMed ID: 26662399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet secretory granules and associated proteins.
    White JG
    Lab Invest; 1993 May; 68(5):497-8. PubMed ID: 7684474
    [No Abstract]   [Full Text] [Related]  

  • 28. DOPA-negative melanocytes in the outer root sheath of human hair follicles express premelanosomal antigens but not a melanosomal antigen or the melanosome-associated glycoproteins tyrosinase, TRP-1, and TRP-2.
    Horikawa T; Norris DA; Johnson TW; Zekman T; Dunscomb N; Bennion SD; Jackson RL; Morelli JG
    J Invest Dermatol; 1996 Jan; 106(1):28-35. PubMed ID: 8592077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy.
    Okamoto T; Irie RF; Fujii S; Huang SK; Nizze AJ; Morton DL; Hoon DS
    J Invest Dermatol; 1998 Dec; 111(6):1034-9. PubMed ID: 9856813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2).
    Kemp EH; Gawkrodger DJ; Watson PF; Weetman AP
    Clin Exp Immunol; 1997 Sep; 109(3):495-500. PubMed ID: 9328128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fate of melanocytes during development of the hair follicle pigmentary unit.
    Botchkareva NV; Botchkarev VA; Gilchrest BA
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):76-9. PubMed ID: 12894999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered N-glycosylation in macrophage x melanoma fusion hybrids.
    Pawelek JM; Chakraborty AK; Rachkovsky ML; Orlow SJ; Bolognia JL; Sodi SA
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1011-27. PubMed ID: 10644005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cotransfection of genes encoding human tyrosinase and tyrosinase-related protein-1 prevents melanocyte death and enhances melanin pigmentation and gene expression of Lamp-1.
    Luo D; Chen H; Jimbow K
    Exp Cell Res; 1994 Jul; 213(1):231-41. PubMed ID: 8020595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biogenesis and role of the lysosomal membrane glycoproteins].
    Saitoh O; Fukuda M
    Tanpakushitsu Kakusan Koso; 1992 Aug; 37(11 Suppl):1873-9. PubMed ID: 1410476
    [No Abstract]   [Full Text] [Related]  

  • 35. Vitiligo. Clinical picture and pathogenesis.
    McBurney EI
    Arch Intern Med; 1979 Nov; 139(11):1295-7. PubMed ID: 508039
    [No Abstract]   [Full Text] [Related]  

  • 36. Increase of pro-opiomelanocortin mRNA prior to tyrosinase, tyrosinase-related protein 1, dopachrome tautomerase, Pmel-17/gp100, and P-protein mRNA in human skin after ultraviolet B irradiation.
    Suzuki I; Kato T; Motokawa T; Tomita Y; Nakamura E; Katagiri T
    J Invest Dermatol; 2002 Jan; 118(1):73-8. PubMed ID: 11851878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of autoantibodies against tyrosinase-related proteins following DNA vaccination: unexpected reactivity to a protein paralogue.
    Srinivasan R; Houghton AN; Wolchok JD
    Cancer Immun; 2002 Jul; 2():8. PubMed ID: 12747753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.
    van den Wijngaard RM; Asghar SS; Pijnenborg AC; Tigges AJ; Westerhof W; Das PK
    Br J Dermatol; 2002 Jan; 146(1):80-7. PubMed ID: 11841370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the etiology of contact/occupational vitiligo.
    Boissy RE; Manga P
    Pigment Cell Res; 2004 Jun; 17(3):208-14. PubMed ID: 15140065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens. An avian model for human vitiligo.
    Austin LM; Boissy RE
    Am J Pathol; 1995 Jun; 146(6):1529-41. PubMed ID: 7778691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.